Jpm. Dam et al., ROLE OF LIPOXYGENASE PRODUCTS IN THE EFFECTS OF ANGIOTENSIN-II IN THEISOLATED AORTA AND PERFUSED HEART OF THE RAT, Mediators of inflammation, 4(6), 1995, pp. 417-425
THE objective of this study was to determine whether arachidonate meta
bolites are involved in the vasoconstrictive effects of angiotensin II
in rats. In the isolated perfused heart, dexamethasone (4 mg/kg) sign
ificantly suppressed the maximal decreases in coronary flow induced by
angiotensin II and vasopressin (reference drug), In the heart, the no
nselective lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA, 1 m
u M) markedly suppressed the angiotensin II-induced decreases in coron
ary flow, NDGA (10 mu M) inhibited both angiotensin II- and methoxamin
e(reference drug) induced contractions in aortic rings with (in the pr
esence of L-NAME) and without endothelium. In the heart, the leukotrie
ne synthesis inhibitor MK-886 (0.3 mu M) significantly reduced the max
imal effects to angiotensin II, but the leukotriene antagonist FPL 557
12 (0.1 and 0.3 mu M) had no effect. We conclude that in the isolated
perfused rat heart angiotensin II-induced decreases hn coronary now ar
e in part mediated by lipoxygenase products, which might be derived fr
om the 5-lipoxygenase pathway, but are probably not leukotrienes. Furt
hermore, endothelium independent lipoxygenase products mediate part of
the contractile responses to angiotensin II in the isolated rat aorta
.